Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Subcutaneous Injection of Organophosphate: A Case Report Publisher



Zoofaghari S1 ; Dehkordi AF1 ; Nemati K1 ; Hashemzadeh M2, 3 ; Otroshi A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Clinical Toxicology Research Center, Department of Clinical Toxicology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Medical Library and Information Science, School of Management and Medical Informat, Sciences, Clinical Informationist Research Group, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Medical Library and Information Science, School of Management and Medical Informat, Sciences, Clinical Informationist Research Group, Isfahan University of medical sciences, Isfahan, Iran

Source: International Journal of Medical Toxicology and Forensic Medicine Published:2021


Abstract

Organophosphate (OP) poisoning is prevalent in developing countries. Toxicity occurs by voluntary injection, inhalation, and absorption. Self-injection is rare. The current case report describes a 61-y/o male with subcutaneous self-injected one cc OP poisoning presenting with delayed drowsiness, nausea, and vomiting. He was treated and presented a good clinical response to treatment with pralidoxime and had a successful recovery. Diagnosis of OP compound toxicity by the parenteral route is a challenge. By observing patients, the dose, and the time between poisoning until the time to start treatment, we can conclude different presentations and outcomes of OP poisoning. © 2021 Shahid Beheshti University of Medical Sciences. All rights reserved.
Related Docs
Experts (# of related papers)